Intarcia Therapeutics, a company based in Boston, MA, is showing off its new Medici Drug Delivery System. The package consists of a drug pump about the size of a wooden match, a delivery system, and a method for stabilizing the cargo within the device such as proteins, peptides, and antibodies.
The implant is positioned just below the skin, and an osmotic pump within uses extracellular fluid entering at one end to drive a tiny piston that evenly pushes the drug at the other end.
The pump can be set to produce just the right rate of drug release for each specific application.
“Delivering drugs via our new technology has the potential to open up a new way of delivering novel medicines just once-yearly,” said Kurt Graves, Chairman, President and CEO of Intarcia, in a statement. “One of the biggest problems in chronic diseases is millions of patients lack effective control of their condition due to sub-optimal effectiveness of their medication, and the fact is, the majority of patients with chronic conditions stop taking these pills and injections, after just three-to-six months. We are aiming to address these serious and costly unmet needs by introducing a new way to deliver once-yearly therapies that hold the potential for game-changing improvements in outcomes and patient adherence over time. We believe that our novel technology platform, the Medici Drug Delivery System, represents the potential for a renaissance in medicine delivery for the treatment of major chronic diseases.”
Product page: Medici Drug Delivery System…